Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
about
The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.Radiologic evaluation of nonalcoholic fatty liver diseaseThe diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisGender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetesQuantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Expectations from imaging for pre-transplant evaluation of living donor liver transplantation.Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI.Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patientsFatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*).Metabolic syndrome and hepatic resection: improving outcomeHeterogeneous living donor hepatic fat distribution on MRI chemical shift imagingLiver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis.Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?Association of serum alanine aminotransferase levels with cardiometabolic risk factors in normal-weight and overweight children.Expanded criteria donors.Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trialsAdult living donor liver imagingIncreased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetesCT Hounsfield numbers of soft tissues on unenhanced abdominal CT scans: variability between two different manufacturers' MDCT scanners.Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD.Assessment of liver fat in an obese patient population using noncontrast CT fat percent index.Quantification of liver fat with magnetic resonance imaging.Colorectal liver metastases: state of the art imaging.State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization.Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.Short- and Long-Term Reproducibility of Intrahepatic Lipid Quantification by 1H-MR Spectroscopy and CT in Obesity.Metabolic profile in right lobe living donor hepatectomy: Comparison of lactated Ringer's solution and normal saline versus acetate based balanced salt solution - a pilot study.Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).Preoperative CT evaluation of potential donors in living donor liver transplantation.Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis.Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population.Grading fatty liver by ultrasound time-domain radiofrequency signal analysis: an in vivo study of rats.Accuracy of computed tomography for detecting hepatic steatosis in donors for liver transplantation: A meta-analysis.Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.Comparison of new and conventional versions of model-based iterative reconstruction in reduced-dose computed tomography for diagnosis of hepatic steatosis.[CT and MRI of the liver: when, what, why?]
P2860
Q27008277-CB851B5F-3FA1-43C6-80A0-23418E582957Q30413672-B531930A-6F8A-4008-BFC7-74953386BD0BQ30436162-F0109E5E-9300-4A2C-8854-3856CF84259FQ30497534-5F8C782C-5D02-4253-8DAD-21B2D743114CQ33892867-AE911A88-08BB-4571-A9CA-9FF68019922AQ34021973-50E6C3F5-0539-4BD7-BDD4-0E1E44391B9BQ34251813-A73C8774-825A-401E-B3BB-CABDD9F2D5F7Q34325362-D7B71B2C-3453-4F18-AF95-4CA414A158E5Q35038752-287B7E2C-8C15-46AF-A968-3790562D5AE0Q35103486-A32CDF08-CEC4-466B-8F97-227793CDC4CAQ35629684-FE13985F-F9E0-49E0-A921-A21A1A860DD7Q35782486-3AE39095-478B-4990-BE71-9932E443AB7BQ35995651-30F3E06E-D8BF-4590-9C05-3181182423AFQ36037915-E52E46EA-68C7-48F5-BE43-16C54AC0614EQ36082368-2C70CA46-18A2-4CEF-91BE-2F420F62CA44Q36244853-42A8578D-88EC-400E-8881-26C708F71230Q36733650-2BA9F4E2-8013-4202-A202-518460B66374Q36762917-D9CF8FDE-ECB9-40BE-8A6B-D1E07D37610EQ36878985-E8599CD0-7D81-45E7-85F3-92AE4322349DQ37060889-6A12D0BA-77F2-4DC5-AE4F-29165B9443B2Q37240894-57B61639-ECB7-442F-9E4C-E0EAA0CED989Q37601122-DE6C5D1E-AE5C-42DC-92F9-50D375A67984Q37722316-4CFFDFB2-8168-47E5-BA50-7D6F48FD29A2Q37811338-10F023ED-A4A1-4659-8DE9-7D5449FFE9BDQ38056872-01CA72AB-EE34-413C-A55C-249B5643EDF2Q38923545-FA480BDF-223F-457D-9047-FCC35F52D40BQ39892915-E814A7F1-84F2-4302-A306-9FBEDF69B4F4Q41104879-4A511F0F-9523-49AE-8965-6C1CEB174F0DQ41464448-BF14B8A7-32D3-4686-91DA-3C7AF86C9CA1Q41712554-79D23C2B-B8C0-4607-836C-CB55D7D7931EQ42247760-4281031F-A738-469E-A50C-4FB497BA8F0FQ44931170-CD150DA1-E45C-4637-BAC6-FBCCB78949F5Q46238230-D3B5C3BE-378F-42A8-888A-84DAA801932AQ47563558-1C5A31B2-0EE8-4214-81BD-EE5290A5A7D1Q48127615-B18993AB-7AA3-4092-84EA-D721FE0A73C1Q48217549-66458F6E-EE03-40B5-985B-A98444247260Q50027558-26E4497E-F019-464B-84B2-F31C12DA1A21Q51316416-5BA9A3F1-DBF5-41F0-9988-21C29E2DE58CQ51500720-2FB0FBAD-50D9-4BDE-BE30-354FF35EFEA4Q52949282-59ACAECD-3B4C-4FA5-8747-1F2339CA841E
P2860
Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Unenhanced CT for assessment o ...... with liver attenuation index.
@en
type
label
Unenhanced CT for assessment o ...... with liver attenuation index.
@en
prefLabel
Unenhanced CT for assessment o ...... with liver attenuation index.
@en
P2093
P1433
P1476
Unenhanced CT for assessment o ...... with liver attenuation index.
@en
P2093
Eugene K Choi
Eun Sil Yu
Kyoung Ho Lee
Kyoung Won Kim
Pyo Nyun Kim
Sang Won Lee
Seong Ho Park
Shin Hwang
Sung-Gyu Lee
Yong Moon Shin
P304
P356
10.1148/RADIOL.2442061177
P407
P577
2007-08-01T00:00:00Z